dan 2163 has been researched along with Benign Neoplasms in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "One hundred six consecutive cancer outpatients with depressive symptoms were treated in a prospective, intention to treat, 4-week study, and were evaluated in single-blind with Montgomery Asberg rating scale for depression (MADRS), clinical global impression (CGI) and dosage record treatment emergent symptom scale (DOTES) to assess side effects of treatment." | 1.34 | Amisulpride in the short-term treatment of depressive and physical symptoms in cancer patients during chemotherapies. ( Berra, C; Binaschi, L; Borio, R; Torta, R, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Torta, R | 1 |
| Berra, C | 1 |
| Binaschi, L | 1 |
| Borio, R | 1 |
1 other study available for dan 2163 and Benign Neoplasms
| Article | Year |
|---|---|
Amisulpride in the short-term treatment of depressive and physical symptoms in cancer patients during chemotherapies.
Topics: Adult; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Cohort Studies; Depression; Femal | 2007 |